Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The purpose of this study is to determine the safety and efficacy of natalizumab in individuals diagnosed with moderate to severely active Crohn\'s disease. It is thought that natalizumab may stop the movement of certain cells, known as white blood cells, into bowel tissue. These cells are thought to cause damage in the bowel leading to the symptoms of Crohn\'s disease.
Epistemonikos ID: 9f10f07cd961f23a95e558695c8b41f6f3a1dd37
First added on: May 03, 2024